The aim of this study was to establish an animal model of HepG2 liver cancer in nude mice, and to inhibit the expression of MTH1 gene in tumor cells by siRNA interference. To study the therapeutic effect of down-regulation of MTH1 expression on HepG2 tumor in nude mice, and to provide a new strategy for the treatment of HCC. Methods: Human HepG2 cells were cultured and transplanted tumor models were established under the armpit of right forelimb of nude mice. The successful nude mice were randomly divided into two groups: control group (CT) and siRNA transfection group (MTH1). The tumor volume of each group of nude mice was consistent. This experiment was mainly conducted by injecting siRNAs into tumor-bearing nude mice and transfection reagents in vivo. The survival time and living condition of nude mice were observed. The tumor inhibition was evaluated by measuring the volume and weight of solid tumor in nude mice. After the administration, The expression of mth1 and its related genes were detected by qPCR to determine the effect of QPCR on the mRNA expression of each gene. The relative expression of mth1 and related proteins in tumor tissues was detected by Elisa and Western blotting. The effect of siRNA on the protein level of each gene was evaluated by calculating the gray value and comparing the od value. Results: The animal model of HepG2 liver cancer in nude mice was successfully established, and the tumorigenesis rate was 100%. The siRNA transfection group had significant anti-tumor effect and significantly inhibited the growth of tumor cells. Survival rate of nude mice in each group was 100%. Compared with the control group, In the transfected group, the expression of mth1 mRNA and protein decreased significantly in the tumor tissues. The expression of caspase-3 protein was significantly increased in the transfected group. Conclusion: SiRNA-MTH1 can effectively silence the expression of MTH1 gene. Down-regulation of mth1 gene expression by siRNA can inhibit the growth, proliferation and apoptosis of HepG2 tumor cells.
Nude mice, HepG2 CELL, saRNA, MTH1
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. International Journal of Cancer, 2015, 136(5): E359.
- Jemal A. Global Cancer Statistics (vol 61, pg 69, 2011)[J]. Ca A Cancer Journal for Clinicians, 2011, 61(2): 134-134.
- Mikhail S, Cosgrove D, Zeidan A. Hepatocellular carcinoma: systemic therapies and future perspectives[J]. Expert Review of Anticancer Therapy, 2014, 14(10): 1205-1218.
- Asal F, Winta Woldai H, Marina I, et al. Analysis of mutant frequencies and mutation spectra in hMTH1 knockdown TK6 cells exposed to UV radiation[J]. Mutation Research/fundamental & Molecular Mechanisms of Mutagenesis, 2013, 751-752(5):8.
- Gad H, Koolmeister T, Jemth A S, et al. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool[J]. Nature, 2014, 508(7495):215-21.
- Helleday T. Cancer phenotypic lethality, exemplified by the non-essential MTH1 enzyme being required for cancer survival[J]. Annals of Oncology, 2014, 25(7):1253.
- Castel S E, Martienssen R A. RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond[J]. Nature Reviews Genetics, 2013, 14(2): 100-112.
- Carthew R W, Sontheimer E J. Origins and mechanisms of miRNAs and siRNAs[J]. Cell, 2009, 136(4): 642-655.
- Thomson T, Lin H. The biogenesis and function PIWI proteins and piRNAs: progress and prospect[J]. Annual review of cell and developmental biology, 2009, 25: 355.
- Kim V N, Han J, Siomi M C. Biogenesis of small RNAs in animals[J]. Nature reviews Molecular cell biology, 2009, 10(2): 126-139.
- Bartel D P. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. cell, 2004, 116(2): 281-297.
- Song J J, Liu J, Tolia N H, et al. The crystal structure of the Argonaute2 PAZ domain reveals an RNA binding motif in RNAi effector complexes[J]. Nature Structural & Molecular Biology, 2003, 10(12): 1026-1032.
- Bagijn M P, Goldstein L D, Sapetschnig A, et al. Function, targets, and evolution of Caenorhabditis elegans piRNAs[J]. Science, 2012, 337(6094): 574-578.
- Landry C D, Kandel E R, Rajasethupathy P. New mechanisms in memory storage: piRNAs and epigenetics[J]. Trends in neurosciences, 2013, 36(9): 535-542.
- Volpe T A, Kidner C, Hall I M, et al. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi[J]. science, 2002, 297(5588): 1833-1837.
- Robb G B, Brown K M, Khurana J, et al. Specific and potent RNAi in the nucleus of human cells[J]. Nature structural & molecular biology, 2005, 12(2): 133-137.
- Burton N O, Burkhart K B, Kennedy S. Nuclear RNAi maintains heritable gene silencing in Caenorhabditis elegans[J]. Proceedings of the National Academy of Sciences, 2011, 108(49): 19683-19688.
- Morris K V, Chan S W L, Jacobsen S E, et al. Small interfering RNA-induced transcriptional gene silencing in human cells[J]. Science, 2004, 305(5688): 1289-1292.
- Weinberg M S, Villeneuve L M, Ehsani A L I, et al. The antisense strand of small interfering RNAs directs histone methylation and transcriptional gene silencing in human cells[J]. Rna, 2006, 12(2): 256-262.
- Bühler M, Verdel A, Moazed D. Tethering RITS to a nascent transcript initiates RNAi-and heterochromatin-dependent gene silencing[J]. Cell, 2006, 125(5): 873-886.
- Guang S, Bochner A F, Burkhart K B, et al. Small regulatory RNAs inhibit RNA polymerase II during the elongation phase of transcription[J]. Nature, 2010, 465(7301): 1097-1101.
Cite this Article:
International Journal of Sciences is Open Access Journal.
This article is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Author(s) retain the copyrights of this article, though, publication rights are with Alkhaer Publications.